| Samuel Hyojune Kim, MD | |
|
2501 Parkers Ln, Alexandria, VA 22306-3209 | |
| (703) 664-7000 | |
| (703) 664-7666 |
| Full Name | Samuel Hyojune Kim |
|---|---|
| Gender | Male |
| Speciality | Critical Care (intensivists) |
| Experience | 12 Years |
| Location | 2501 Parkers Ln, Alexandria, Virginia |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1174889141 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Inova Mount Vernon Hospital | Alexandria, VA | Hospital |
| Inova Fairfax Hospital | Falls church, VA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Inova Health Care Services | 2466351093 | 1725 |
News Archive
Global Health Partner: FIRST QUARTER 2011. Revenues increased by 27 percent to SEK 178.9 million.
Sanofi announced today that Auvi-Q (epinephrine injection, USP) is now available in U.S. retail pharmacies nationwide with a prescription from a healthcare provider.
New research will seek to understand the biological mechanisms that are triggered by exposure to air pollution during pregnancy and lead to lower birth weight in newborns, placing them at greater risk for chronic conditions such as coronary heart disease and hypertension later in life.
Alexion Pharmaceuticals, Inc. announced that it has purchased patents and assets from Germany-based Orphatec Pharmaceuticals GmbH related to an investigational therapy for patients with molybdenum cofactor deficiency (MoCD) Type A, a devastating ultra-rare genetic disorder characterized by severe brain damage and rapid death in newborns.
› Verified 3 days ago
| Entity Name | Inova Health Care Services |
|---|---|
| Entity Type | Part B Supplier - Hospital Department(s) |
| Entity Identifiers | NPI Number: 1952320061 PECOS PAC ID: 2466351093 Enrollment ID: O20110104000695 |
News Archive
Global Health Partner: FIRST QUARTER 2011. Revenues increased by 27 percent to SEK 178.9 million.
Sanofi announced today that Auvi-Q (epinephrine injection, USP) is now available in U.S. retail pharmacies nationwide with a prescription from a healthcare provider.
New research will seek to understand the biological mechanisms that are triggered by exposure to air pollution during pregnancy and lead to lower birth weight in newborns, placing them at greater risk for chronic conditions such as coronary heart disease and hypertension later in life.
Alexion Pharmaceuticals, Inc. announced that it has purchased patents and assets from Germany-based Orphatec Pharmaceuticals GmbH related to an investigational therapy for patients with molybdenum cofactor deficiency (MoCD) Type A, a devastating ultra-rare genetic disorder characterized by severe brain damage and rapid death in newborns.
› Verified 3 days ago
| Entity Name | Commonwealth Emergency Physicians Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1598723082 PECOS PAC ID: 7618870312 Enrollment ID: O20141104000471 |
News Archive
Global Health Partner: FIRST QUARTER 2011. Revenues increased by 27 percent to SEK 178.9 million.
Sanofi announced today that Auvi-Q (epinephrine injection, USP) is now available in U.S. retail pharmacies nationwide with a prescription from a healthcare provider.
New research will seek to understand the biological mechanisms that are triggered by exposure to air pollution during pregnancy and lead to lower birth weight in newborns, placing them at greater risk for chronic conditions such as coronary heart disease and hypertension later in life.
Alexion Pharmaceuticals, Inc. announced that it has purchased patents and assets from Germany-based Orphatec Pharmaceuticals GmbH related to an investigational therapy for patients with molybdenum cofactor deficiency (MoCD) Type A, a devastating ultra-rare genetic disorder characterized by severe brain damage and rapid death in newborns.
› Verified 3 days ago
| Entity Name | Commonwealth Critical Care Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1891210035 PECOS PAC ID: 4284909029 Enrollment ID: O20171004003466 |
News Archive
Global Health Partner: FIRST QUARTER 2011. Revenues increased by 27 percent to SEK 178.9 million.
Sanofi announced today that Auvi-Q (epinephrine injection, USP) is now available in U.S. retail pharmacies nationwide with a prescription from a healthcare provider.
New research will seek to understand the biological mechanisms that are triggered by exposure to air pollution during pregnancy and lead to lower birth weight in newborns, placing them at greater risk for chronic conditions such as coronary heart disease and hypertension later in life.
Alexion Pharmaceuticals, Inc. announced that it has purchased patents and assets from Germany-based Orphatec Pharmaceuticals GmbH related to an investigational therapy for patients with molybdenum cofactor deficiency (MoCD) Type A, a devastating ultra-rare genetic disorder characterized by severe brain damage and rapid death in newborns.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Samuel Hyojune Kim, MD Po Box 37174, Baltimore, MD 21297-3174 Ph: (571) 423-5699 | Samuel Hyojune Kim, MD 2501 Parkers Ln, Alexandria, VA 22306-3209 Ph: (703) 664-7000 |
News Archive
Global Health Partner: FIRST QUARTER 2011. Revenues increased by 27 percent to SEK 178.9 million.
Sanofi announced today that Auvi-Q (epinephrine injection, USP) is now available in U.S. retail pharmacies nationwide with a prescription from a healthcare provider.
New research will seek to understand the biological mechanisms that are triggered by exposure to air pollution during pregnancy and lead to lower birth weight in newborns, placing them at greater risk for chronic conditions such as coronary heart disease and hypertension later in life.
Alexion Pharmaceuticals, Inc. announced that it has purchased patents and assets from Germany-based Orphatec Pharmaceuticals GmbH related to an investigational therapy for patients with molybdenum cofactor deficiency (MoCD) Type A, a devastating ultra-rare genetic disorder characterized by severe brain damage and rapid death in newborns.
› Verified 3 days ago
George Peter Silis, MD Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 5115 Franconia Road, Sutie G, Alexandria, VA 22310 Phone: 703-922-4222 Fax: 703-922-4253 | |
Dr. Madhusudanan Srambickal Ramaswamy, M.D., M.S. Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 4320 Seminary Rd, Alexandria, VA 22304 Phone: 703-504-3000 Fax: 571-285-0027 | |
Nabeela Tabassum, M.D. Critical Care Medicine Medicare: Not Enrolled in Medicare Practice Location: 4810 Beauregard St, Ste 303, Alexandria, VA 22312 Phone: 703-750-0108 Fax: 703-750-0230 | |
Dr. Chinedu Madu, MD Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 4825 Mark Center Dr Ste 150, Alexandria, VA 22311 Phone: 703-751-8111 Fax: 703-751-1105 | |
Kim-dung T Nguyen, M.D. Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 5130 Duke St, 8, Alexandria, VA 22304 Phone: 703-823-2849 Fax: 703-823-2847 | |
Dr. Muhammed F. Khokhar, Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 4660 Kenmore Ave Ste 810, Alexandria, VA 22304 Phone: 703-823-0333 Fax: 703-823-8611 | |
Tariq Rehman, MD Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 4141a Duke St, Alexandria, VA 22304 Phone: 703-461-3556 Fax: 703-461-8075 |